Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Antonio Molina-Carballo, Ana Checa-Ros & Antonio Muñoz-Hoyos. (2016) Treatments and compositions for attention deficit hyperactivity disorder: a patent review. Expert Opinion on Therapeutic Patents 26:7, pages 799-814.
Read now
Read now
Philip F Saltiel & Daniel I Silvershein. (2015) Major depressive disorder: mechanism-based prescribing for personalized medicine. Neuropsychiatric Disease and Treatment 11, pages 875-888.
Read now
Read now
Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand & Chi-Un Pae. (2015) Five potential therapeutic agents as antidepressants: a brief review and future directions. Expert Review of Neurotherapeutics 15:9, pages 1015-1029.
Read now
Read now
Sheng-Min Wang, Changsu Han & Chi-Un Pae. (2015) Criticisms of drugs in early development for the treatment of depression: what can be improved?. Expert Opinion on Investigational Drugs 24:4, pages 445-453.
Read now
Read now
Articles from other publishers (15)
Li Yan, Jiawei Wang, Xiang He, Yufan Jin, Pan Chen, Yang Bai, Peibo Li & Weiwei Su. (2022) Platycladus orientalis seed extract as a potential triple reuptake MAO inhibitor rescue depression phenotype through restoring monoamine neurotransmitters. Journal of Ethnopharmacology 295, pages 115302.
Crossref
Crossref
Weiwei Xue, Tingting Fu, Guoxun Zheng, Gao Tu, Yang Zhang, Fengyuan Yang, Lin Tao, Lixia Yao & Feng Zhu. (2020) Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters. Current Medicinal Chemistry 27:23, pages 3830-3876.
Crossref
Crossref
Wei Guo, Yonglin Gao, Wanglin Jiang, Chunmei Li, Fei Lin, Haibo Zhu, Hongbo Wang, Liang Ye, Jia Grace Qi, Xiaobo Cen & Jingwei Tian. (2018) Toxicity effects of a novel potent triple reuptake inhibitor, LPM570065, on the fertility and early embryonic development in Sprague-Dawley rats. Regulatory Toxicology and Pharmacology 100, pages 45-51.
Crossref
Crossref
Suresh Paudel, Xiao Min, Srijan Acharya, Daulat Bikram Khadka, Goon Yoon, Kyeong-Man Kim & Seung Hoon Cheon. (2018) Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake. Bioorganic & Medicinal Chemistry 26:20, pages 5538-5546.
Crossref
Crossref
Murugaiah A. M. Subbaiah. (2017) Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges. Journal of Medicinal Chemistry 61:6, pages 2133-2165.
Crossref
Crossref
Weiwei Xue, Panpan Wang, Gao Tu, Fengyuan Yang, Guoxun Zheng, Xiaofeng Li, Xiaoxu Li, Yuzong Chen, Xiaojun Yao & Feng Zhu. (2018) Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder. Physical Chemistry Chemical Physics 20:9, pages 6606-6616.
Crossref
Crossref
Suresh Paudel, Xiao Min, Srijan Acharya, Daulat Bikram Khadka, Goo Yoon, Kyeong-Man Kim & Seung Hoon Cheon. (2017) Triple reuptake inhibitors: Design, synthesis and structure–activity relationship of benzylpiperidine–tetrazoles. Bioorganic & Medicinal Chemistry 25:20, pages 5278-5289.
Crossref
Crossref
Suresh Paudel, Srijan Acharya, Goo Yoon, Kyeong-Man Kim & Seung Hoon Cheon. (2017) Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors. Bioorganic & Medicinal Chemistry 25:7, pages 2266-2276.
Crossref
Crossref
Guoxun Zheng, Weiwei Xue, Panpan Wang, Fengyuan Yang, Bo Li, Xiaofeng Li, Yinghong Li, Xiaojun Yao & Feng Zhu. (2016) Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study. Scientific Reports 6:1.
Crossref
Crossref
Hongjia Zhang, Rongsheng Tong, Lan Bai, Jianyou Shi & Liang Ouyang. (2016) Emerging targets and new small molecule therapies in Parkinson’s disease treatment. Bioorganic & Medicinal Chemistry 24:7, pages 1419-1430.
Crossref
Crossref
Laurence Lalanne, Pierre-Eric Lutz, Benoit Trojak, Jean-Philippe Lang, Brigitte L. Kieffer & Elisabeth Bacon. (2016) Medications between psychiatric and addictive disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, pages 215-223.
Crossref
Crossref
Ikuo Fujimori, Tomoya Yukawa, Taku Kamei, Yoshihisa Nakada, Nobuki Sakauchi, Masami Yamada, Yusuke Ohba, Maiko Takiguchi, Masako Kuno, Izumi Kamo, Hideyuki Nakagawa, Teruki Hamada, Tomoko Igari, Teruaki Okuda, Satoshi Yamamoto, Tetsuya Tsukamoto, Yuji Ishichi & Hiroyuki Ueno. (2015) Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor. Bioorganic & Medicinal Chemistry 23:15, pages 5000-5014.
Crossref
Crossref
Berend Olivier. (2015) Serotonin: A never-ending story. European Journal of Pharmacology 753, pages 2-18.
Crossref
Crossref
Minsoo Han, Chiman Song, Nakcheol Jeong & Hoh-Gyu Hahn. (2014) Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-Oxyazetidine. ACS Medicinal Chemistry Letters 5:9, pages 999-1004.
Crossref
Crossref
Jun Yun, Minsoo Han, Chiman Song, Seung Hoon Cheon, Kihang Choi & Hoh-Gyu Hahn. (2014) Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters 24:15, pages 3234-3237.
Crossref
Crossref